Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & President
26 juil. 2022 16h15 HE
|
Summit Therapeutics Inc.
Menlo Park, California, July 26, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Maky Zanganeh, DDS, MBA, has been appointed as Co-Chief Executive Officer &...
Summit Therapeutics Provides Update on Ridinilazole
14 juil. 2022 08h30 HE
|
Summit Therapeutics Inc.
Menlo Park, CA, July 14, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today provided an update with respect to the clinical development of...
Summit Therapeutics Announces $100 Million Rights Offering
22 juin 2022 16h30 HE
|
Summit Therapeutics Inc.
Menlo Park, CA, June 22, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has approved a rights...
Global Microbiome Market Report 2022: A $10+ Billion Market by 2026 - Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F
20 juin 2022 04h13 HE
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Report 2022: By Type, By Application, By Technology" report has been added to ResearchAndMarkets.com's offering. The global...
Human Microbiome Market, 2035
08 juin 2022 04h08 HE
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Human Microbiome Market: Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy: Distribution by Type of Molecule, Type of Product, Target...
Global Human Microbiome Market Report to 2028 - Industry Analysis, Size, Share, Growth, Trends, and Forecasts
16 mai 2022 04h58 HE
|
Research and Markets
Dublin, May 16, 2022 (GLOBE NEWSWIRE) -- The "Human Microbiome Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028" report has been added to...
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2022
11 mai 2022 16h30 HE
|
Summit Therapeutics Inc.
Cambridge, MA, May 11, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational...
Prebiotic and Probiotic Synergy with Pro+ Synbiotic Supports Allergy Relief Through Balanced Gut Health
27 avr. 2022 09h10 HE
|
Wakunaga of America: Kyo-Dophilus Probiotics
MISSION VIEJO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Seasonal allergy sufferers will try just about anything to reduce the discomforts associated with the change of the seasons from winter to...
Taconic Biosciences and Biomodels Establish Microbiome Initiative
26 avr. 2022 09h00 HE
|
Taconic Biosciences
RENSSELAER, N.Y., April 26, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, and Biomodels, a provider of contract research services...
State of the Biopharmaceutical Industry, 2022 Report - As Industries Emerge from the impact of COVID-19, 2022 will be a Year of Readjustments and Transition
25 avr. 2022 08h23 HE
|
Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2022" report has been added to ResearchAndMarkets.com's offering. In this "State of the Biopharmaceutical...